157 results
Page 2 of 8
8-K/A
EX-99.3
lie7okv6f6
2 Nov 23
Financial Statements and Exhibits
4:05pm
S-3ASR
53uqv usl8
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
b1r6m5 rwdeyhh63u
13 Oct 23
Other Events
4:16pm
8-K
EX-10.1
1w930j15lwn7d2
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.1
8q9xitm2x ei4pkr99
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-2.1
m08mtiw
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-4.1
2pbj v0j8ph
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
hg6b4n9n
6 Apr 23
Departure of Directors or Certain Officers
7:31am
8-K
gbigjhtu t6
19 Dec 22
Departure of Directors or Certain Officers
8:30am
S-3ASR
EX-4.3
yyh xnde81hywzv3
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
8kj1lflc4c 8ib2y6in
9 Sep 22
Automatic shelf registration
4:31pm
424B5
j98viuw 8s1ny8ml
10 Aug 22
Prospectus supplement for primary offering
5:07pm
8-K
EX-1.1
dl4 fl109
10 Aug 22
Other Events
12:00am
424B5
lraaz
9 Aug 22
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
iiu9rurklkaz0
4 Aug 22
Results of Operations and Financial Condition
4:03pm